EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Lifetime Health and Economic Burden of Smokeless Tobacco use in Bangladesh, India, and Pakistan: Results From ASTRAMOD

Kathryn Coyle, Prashant Kumar Singh iD, Ravi Kaushik, Rumana Huque iD, Zohaib Khan iD, Ravi Mehrotra iD, Kamran Siddiqi iD, Subhash Pokhrel iD

Nicotine and Tobacco Research · 2025

DOI: 10.1093/ntr/ntae067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nicotine and Tobacco Research, 2025. Verfasst von Kathryn Coyle und 7 weiteren Autor:innen. Beteiligte Einrichtung: Health Economics Research Group (HERG), Department of Health Sciences, Brunel University London, Uxbridge, UK. Hauptthemen laut MEDLINE: Tobacco, Smokeless, Cost of Illness. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Under the current policy landscapes, the lifetime health and economic burden of smokeless tobacco (ST) products, consumed by over 297 million ST users in South Asia, is unknown. The aim of this study was to estimate the lifetime health effects and costs attributable to current and future ST use in Bangladesh, India, and Pakistan where the majority of ST users live. Aims and Methods We developed a Markov-based state-transition model (ASTRAMOD) to predict the lifetime costs of treatment of four diseases (oral, pharyngeal, esophageal cancers, and stroke) and disability-adjusted life years (DALYs), attributable to the current and future use of ST under existing ST policy scenario. Country-specific Global Adult Tobacco Surveys, life tables, and meta-analyses of South Asian and South East Asian studies were used to populate the model. A probabilistic sensitivity analysis evaluated the uncertainty in model predictions.

Results

If there were no change in the current ST policies, the lifetime ST-attributable treatment costs would be over US$19 billion in India, over US$1.5 billion in Bangladesh, and over US$3 billion in Pakistan. For all countries, the attributable costs are higher for younger cohorts with costs declining with increasing age for those over 50. The model predicted that a typical 15-year-old male adoloscent would gain 0.07–0.18 life years, avert 0.07–0.19 DALYs, and generate a cost-savings of US$7–21 on healthcare spending if ST policies were changed to eliminate ST use.

Conclusions

Policy interventions aimed at decreasing the uptake of ST and increasing quitting success have the potential to substantially decrease the economic and health burden of ST.

Implications

This study provides the most comprehensive estimates of the lifetime health and economic burden of ST by 5-year age and sex cohorts. This is also the first study that highlights the scale of health and economic burden of ST in Bangladesh, India, and Pakistan if there were no changes in the current ST policies. Policymakers and practitioners can use the reported data to justify their decisions to improve current ST policies and practices in their country. Researchers can use the ASTRAMOD methodology to estimate the impact of future ST policy changes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tobacco, SmokelessCost of IllnessHumansBangladeshPakistanMaleAdultIndiaFemaleMiddle AgedAdolescentDisability-Adjusted Life YearsMarkov ChainsYoung AdultAged

Autor:innen und Institutionen

  • Health Economics Research Group (HERG), Department of Health Sciences, Brunel University London, Uxbridge, UK.
  • Division of Preventive Oncology and Population Health, ICMR-National Institute of Cancer Prevention and Research, Noida, India.
  • Department of Physiology, Maulana Azad Medical College, New Delhi, India.
  • ARK Foundation, Dhaka, Bangladesh.
  • Office of Research, Innovation, and Commercialization, Khyber Medical University, Peshawar, Pakistan.
  • Centre for Health Innovation and Policy (CHIP) Foundation, Noida, India.

ORCID-Profile: Prashant Kumar Singh, Rumana Huque, Zohaib Khan, Ravi Mehrotra, Kamran Siddiqi, Subhash Pokhrel

Förderung

  • UK government

Zitieren

APA

Coyle, K., Singh, P. K., Kaushik, R., Huque, R., Khan, Z., Mehrotra, R., Siddiqi, K., & Pokhrel, S. (2025). The Lifetime Health and Economic Burden of Smokeless Tobacco use in Bangladesh, India, and Pakistan: Results From ASTRAMOD. Nicotine and Tobacco Research. https://doi.org/10.1093/ntr/ntae067

Vancouver

Coyle K, Singh PK, Kaushik R, Huque R, Khan Z, Mehrotra R, et al. The Lifetime Health and Economic Burden of Smokeless Tobacco use in Bangladesh, India, and Pakistan: Results From ASTRAMOD. Nicotine and Tobacco Research. 2025. doi:10.1093/ntr/ntae067

BibTeX
@article{Coyle2025,
  author = {Coyle, Kathryn and Singh, Prashant Kumar and Kaushik, Ravi and Huque, Rumana and Khan, Zohaib and Mehrotra, Ravi and Siddiqi, Kamran and Pokhrel, Subhash},
  title = {The Lifetime Health and Economic Burden of Smokeless Tobacco use in Bangladesh, India, and Pakistan: Results From ASTRAMOD},
  journal = {Nicotine and Tobacco Research},
  year = {2025},
  doi = {10.1093/ntr/ntae067}
}
Kostenlos starten →